Evolving therapies for myocardial ischemia/reperfusion injury

B Ibáñez, G Heusch, M Ovize, F Van de Werf - Journal of the American …, 2015 - jacc.org
The damage inflicted on the myocardium during acute myocardial infarction is the result of 2
processes: ischemia and subsequent reperfusion (ischemia/reperfusion injury). During the …

Heart failure subtypes and cardiomyopathies in women

EM DeFilippis, A Beale, T Martyn, A Agarwal… - Circulation …, 2022 - Am Heart Assoc
Heart failure affects over 2.6 million women and 3.4 million men in the United States with
known sex differences in epidemiology, management, response to treatment, and outcomes …

Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of …

G Pizarro, L Fernández-Friera, V Fuster… - Journal of the American …, 2014 - jacc.org
Objectives: The goal of this trial was to study the long-term effects of intravenous (IV)
metoprolol administration before reperfusion on left ventricular (LV) function and clinical …

Sex differences in advanced heart failure therapies

EM Hsich - Circulation, 2019 - Am Heart Assoc
This in-depth review of sex differences in advanced heart failure therapy summarizes the
existing literature on implantable cardioverter defibrillators, biventricular pacemakers …

Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from …

SB Dunbar, CM Dougherty, SF Sears, DL Carroll… - Circulation, 2012 - Am Heart Assoc
Significant mortality benefits have been documented in recipients of implantable
cardioverter defibrillators (ICDs); however, the psychosocial distress created by the …

Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the …

K Narayanan, K Reinier, A Uy-Evanado… - Circulation, 2013 - Am Heart Assoc
Background—The prevalence rates and influencing factors for deployment of primary
prevention implantable cardioverter defibrillators (ICDs) among subjects who eventually …

Implantable cardioverter-defibrillator use among medicare patients with low ejection fraction after acute myocardial infarction

SD Pokorney, AL Miller, AY Chen, L Thomas… - Jama, 2015 - jamanetwork.com
Importance Implantable cardioverter-defibrillators (ICDs) are not recommended within 40
days of myocardial infarction (MI); thus, ICD implantation might not be considered during the …

A patch wearable cardioverter-defibrillator for patients at risk of sudden cardiac arrest

J Hummel, M Houmsse, G Tomassoni, D Nair… - Journal of the American …, 2024 - jacc.org
Background For many patients, sudden cardiac arrest (SCA) risk is elevated temporarily.
Wearable cardioverter-defibrillators (WCDs) can monitor and treat SCA during these …

Who should receive the subcutaneous implanted defibrillator? The subcutaneous implantable cardioverter defibrillator (ICD) should be considered in all ICD patients …

JE Poole, MR Gold - Circulation: Arrhythmia and Electrophysiology, 2013 - Am Heart Assoc
Poole and Gold S-ICD Pro 1237 in the ICD population, the long-term risks of lead
malfunction and infection become greater concerns. Studies have shown that> 20% of …

Preventive substrate ablation in chronic post-myocardial infarction patients with high-risk scar characteristics for ventricular arrhythmias: rationale and design of …

G Falasconi, D Penela, D Soto-Iglesias… - Journal of Interventional …, 2023 - Springer
Background Recent studies showed that an early strategy for ventricular tachycardia (VT)
ablation resulted in reduction of VT episodes or mortality. Cardiac magnetic resonance …